Drug recall D-0190-2024
Product
Meloxicam Tablets, USP, 15 mg, 1000 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., Kurkumbh, India; Manufactured for: Cipla USA, Inc., 9100 S. Dadeland Blvd., Suite 1500 Miami, FL 33156. NDC: 69097-159-15
Reason for recall
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Lots and codes
Batch KA11489
Recall details
- Recalling firm
- CARDINAL HEALTHCARE, Dublin, OH
- Quantity
- 1 unit
- Distribution
- Nationwide USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 26, 2022
- Terminated
- September 29, 2024
Related products
- Meloxicam – drug information
- NDC 69097-158 Meloxicam · Meloxicam 7.5 mg/1 · Cipla USA Inc.
- NDC 69097-159 Meloxicam · Meloxicam 15 mg/1 · Cipla USA Inc.